Dr. Guglietta: Yes. So, it's exactly the challenge. And what we are actually seeing is that at the moment, especially for ...

Colorectal cancer (CRC ... supporting a polyclonal origin model. Researchers, utilizing a base editor-enabled DNA barcoding system, meticulously mapped the single-cell phylogenies in mouse ...

Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...